Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. - Test2 - elhamkhani - TriplyDB

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

http://www.wikidata.org/entity/Q27851726

about

The epigenetic landscape of acute myeloid leukemia SYK is a critical regulator of FLT3 in acute myeloid leukemia Acute myeloid leukemia in the older adults Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials Midostaurin: an emerging treatment for acute myeloid leukemia patients Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells Epigenetic regulators and their impact on therapy in acute myeloid leukemia Acute Myeloid Leukemia: A Concise Review Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors Functions of TET Proteins in Hematopoietic Transformation Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis Molecular Genetic Markers in Acute Myeloid Leukemia Volasertib for AML: clinical use and patient consideration Genetics of myeloproliferative neoplasms From human genome to cancer genome: the first decade Mechanisms of epigenetic regulation of leukemia onset and progression Connections between TET proteins and aberrant DNA modification in cancer Concise review: Leukemia stem cells in personalized medicine Post-remission therapy for acute myeloid leukemia Molecular prognostic factors in cytogenetically normal acute myeloid leukemia Myeloid malignancies: mutations, models and management Childhood acute myeloid leukaemia Emerging patterns of somatic mutations in cancer Clinical Results of Hypomethylating Agents in AML Treatment Clonal evolution in hematological malignancies and therapeutic implications FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging CIViC database The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations Genomic Classification and Prognosis in Acute Myeloid Leukemia.IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

P2860

2068584010f3c2ab7aef4f721ad69415caad7e87 c64931ba9931e59ea81d7c8468dc6b01331c10e3

P248

Q21284742-85A18308-57D1-4F36-A4BB-AD2900473C29 Q24337247-567BC895-1930-47DA-9197-43A04C1B69D2 Q26740584-31D6F2DD-5C0E-40A9-8B3A-88237BEDF5CB Q26744080-87B28460-D5D4-42AD-9055-00EEE6B098FC Q26744111-D6E50935-C054-4FC9-BD38-4593B6244B40 Q26745731-1478E1BB-6CE6-40F5-AD01-9829E70AF152 Q26749271-CD5DBB06-98C1-473E-ADB7-C46453FDED4B Q26751011-FD843EFD-6E77-43C7-B4AB-52C3617CB2FB Q26765402-42B9AF62-F207-43F5-BE64-69379463F7B6 Q26766719-6542ED06-FEB0-4DBD-A65D-27236AEEC548 Q26768600-4B2440D9-B0A1-4CB6-ACE1-F16FD3345802 Q26771438-58A3CCDF-6C6E-441B-9DE5-12610583D89D Q26777265-AC6B6396-B375-40E1-B6AE-547B64C1DFD8 Q26778323-385D5E03-CF49-4BDC-8B24-8EED1461B855 Q26796514-D1230982-30E3-4F0F-9552-1D73ED857117 Q26797245-D692A94E-83B7-4D4F-8597-963E35519B1F Q26799606-DBA24BFD-1FC4-4B66-9659-8C6E635CCB79 Q26801131-EFD6C52A-2995-408C-9B3D-1E307F2FD005 Q26823651-C38FF09E-4E82-41E2-8015-777648853F9D Q26827640-6019A6B3-FAD9-46F0-A2A0-E8BF2C1884FC Q26861785-C8B00C2C-9811-40FD-9AE1-8519C4ECB291 Q26865671-AEE773FD-1A7E-4575-9981-0CB18B8EAE0A Q26995268-916D45F9-C4A0-4687-98B9-304A6E8E951E Q26995867-9A690BA8-1167-4829-8402-36E1AF9D42E5 Q26998811-497B7F05-A60B-4563-94DE-B2B9682B813F Q27000577-FA117EDE-492E-4016-9B98-B5BCA428A962 Q27005960-1E03EF05-1910-4E47-A4A8-20471E72DE82 Q27014126-751F7F8D-EBB7-43FE-8E8D-D721C23BE19F Q27022725-EACB7050-ECA8-4412-99D8-74CFBD9FDBD3 Q27027655-4CA63BA0-BB52-4394-8304-854D9BD92B0F Q27028163-F7D10463-4E56-4561-884B-1D15F79B20C7 Q27311229-EBB3ACCE-30F8-444B-AF2F-B4DC7729F592 Q27612411-8D8AF7E9-B63A-4717-8CD2-A86E27B8E10D Q27852046-291863C7-A3DC-4F14-807B-193F60054EBB Q27852623-26194E5B-0986-49BA-8E12-7E3532431514 Q27853009-73E51357-CF65-4FA2-93D7-D47DE4E816D3 Q27853083-486D64A9-8DAD-4E2F-B931-F05F5C0A09F5 Q27853094-3726527A-722A-43AB-8AD0-AE1EDA5E0BEC Q27853389-478C6EDF-18C0-4164-9588-019BCA05B120 Q28066926-A138B359-D629-4954-ADC5-9D9AFE5B1E1B

P2860

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

http://www.wikidata.org/entity/Q27851726

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@ast

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@en

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@nl

type

label

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@ast

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@en

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@nl

altLabel

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

@en

prefLabel

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@ast

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@en

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@nl

P1433

Q27851726-3ABED0BB-ED58-48F9-A9A0-53591395521B

P1476

Q27851726-94FC2BB5-AD64-41C0-80F6-4E25D0FE48BA

P2093

Q27851726-0745C3CD-2464-4775-A250-E4A5B8831259

Q27851726-08AE6071-3B05-45D0-98B9-784DA9E7A1AB

Q27851726-1245CE22-FF70-4A99-A152-C9B52AAC763F

Q27851726-1300DA56-779E-4FD3-8EA1-F19FAE946C36

Q27851726-14A883A0-90EF-476D-B519-B13E899D6BCC

Q27851726-17EEC524-AFE5-4373-B943-35DF7CD65B9B

Q27851726-19F1F2EE-44BB-4E12-8AAE-06704E43ED73

Q27851726-2AF82908-600B-4960-A66E-AF77BB9DBF81

Q27851726-3E93C416-368E-406B-A4F6-B951CD3FCE07

Q27851726-4749B5E0-4BBB-4C5B-A072-49148B2FF2EB

P2860

Q27851726-107A26EC-650F-40A1-869A-E762ED28A847

Q27851726-2156DEF2-335F-413E-8AFF-FEBC24429605

Q27851726-2AD21817-30E8-4398-B3BE-986C2D62F043

Q27851726-3550FB86-DCD8-49B8-906A-8EC4BE1996E5

Q27851726-385C50D1-D99D-4046-97F7-2FFD4DD70157

Q27851726-59B5F401-1F40-4CE0-AC73-E264BA403469

Q27851726-5A584B7D-551C-498D-A453-7F825CAEE4E0

Q27851726-65A68F7D-4DB1-41C7-B658-0FE45280AB3A

Q27851726-707E7B08-39AB-42C7-93C5-F5B94AA3E07D

Q27851726-7999E19F-19D1-47AD-8A9D-4266F8338742

P304

Q27851726-F20E40EF-7434-41CE-9772-8BC4FA2148AF

P31

Q27851726-749032F2-356D-4C6B-B627-4DF801519B9C

P3181

Q27851726-7FEABC8C-AA82-4E42-B48C-68EBDB36D850

P356

Q27851726-704896C9-7C18-47AD-BB57-0E2451F1A8F7

P407

Q27851726-72286DF5-347C-4EB4-8705-FAF7A60A1E47

P433

Q27851726-B01E785A-D6D9-413C-925F-7912638BBB47

P478

Q27851726-8EC970BA-8F21-4AAE-B4C1-5C21CE028C27

P50

Q27851726-0407BF60-150F-4876-BD1E-CB5E0155284C

Q27851726-10E01527-7EAC-48B0-A647-9050EF409C9D

Q27851726-4A1A619F-0067-4C03-9BF8-83B55D6A46BC

Q27851726-5E75645B-DAA2-4FFC-B436-DE2310F28E30

Q27851726-8B851408-CEC4-4B6C-96D9-769F46423A25

Q27851726-DAAF07AA-BA58-423B-8340-B06BB039957D

Q27851726-DE898A5A-1452-471C-A1C4-1E80DB743D8E

P577

Q27851726-383935A1-1EA0-47C4-8B6D-9F3A687E89CA

P698

Q27851726-0DE99B87-0986-4632-8A34-007DCA8F59B5

P921

Q27851726-614B8989-E61D-44A8-A779-D44264EC945F

P932

Q27851726-24372E9C-6EEE-4A99-A33A-4502C539408A

P3181

P356

P1433

The New England Journal of Medicine

P1476

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

@en

P2093

Adolfo Ferrando

http://www.w3.org/2001/XMLSchema#string

Adriana Heguy

http://www.w3.org/2001/XMLSchema#string

Agnes Viale

http://www.w3.org/2001/XMLSchema#string

Ari Melnick

http://www.w3.org/2001/XMLSchema#string

Hugo Fernandez

http://www.w3.org/2001/XMLSchema#string

Igor Dolgalev

http://www.w3.org/2001/XMLSchema#string

Jacob M Rowe

http://www.w3.org/2001/XMLSchema#string

Janice Cheng

http://www.w3.org/2001/XMLSchema#string

Janis Racevskis

http://www.w3.org/2001/XMLSchema#string

Jay P Patel

http://www.w3.org/2001/XMLSchema#string

P2860

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Recurring mutations found by sequencing an acute myeloid leukemia genome

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

DNMT3A Mutations in Acute Myeloid Leukemia

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

P304

1079-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

288687

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1112304

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

366

http://www.w3.org/2001/XMLSchema#string

P50

Pieter Van Vlierberghe

Martin S Tallman

Elisabeth Paietta

Hillard M Lazarus

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22417203

http://www.w3.org/2001/XMLSchema#string

P921

P932

3545649

http://www.w3.org/2001/XMLSchema#string